Signature Talk Topics

Each talk can be adapted for 20-minute conference slots, 45-minute keynotes, or 90-minute workshop formats.

What Patients Wish Pharma Knew

The definitive bridge-building talk. Christian draws on 16 years of PLF community relationships to surface what C. diff patients and caregivers actually want from the companies developing treatments and the health systems delivering them. Direct, specific, and actionable. Best for Medical Affairs, patient advocacy teams, and conference audiences across pharma and biotech.

Building a Movement from Loss: The PLF Story

The origin story, told with purpose. Christian traces how grief became mission, how mission became organization, and how PLF grew from a family's response to a preventable death into the only national CDI advocacy infrastructure in the country. Works for nonprofit and foundation audiences, corporate leadership events, and any context organized around mission-driven leadership.

The C. diff Crisis: What 16 Years of Advocacy Taught Me

A comprehensive view of the CDI landscape from the patient advocacy vantage point: where the field has been, what has changed, what has not, and what the next decade requires. Covers policy, clinical culture, public awareness, and community needs. Best for infectious disease conferences, CDI-focused pharma teams, and health system leadership.

Authentic Patient Engagement: Why Most Organizations Get It Wrong

A pragmatic critique and a practical guide. Christian examines common failure modes in pharma-patient engagement, from performative listening to transactional relationships, and lays out what genuine partnership looks like in practice. Includes frameworks for designing patient advisory structures that produce real insight. Best for pharma and corporate audiences.

CDI Policy: Where Federal Action Is Heading and What Industry Should Know

A policy briefing from the inside. Christian reviews the federal CDI policy landscape, the status of pending legislation, CMS and surveillance trends, and what the advocacy and policy environment means for companies with CDI programs. Based on direct Congressional engagement and federal advisory experience. Best for government affairs, market access, and public policy audiences.

Advisory Boards
$2,500.00

Patient/advocate/policy voice for CDI launch strategy, label development, reimbursement positioning, and access programs. Ideal for companies with active or pipeline CDI programs.

$2,500 - $4,000 / meeting

Consulting

Keynote & Conference
$6,000.00

45-60 minutes. Patient experience, CDI public health framing, healthcare system gaps, antimicrobial stewardship advocacy. Industry conferences, launch meetings, medical affairs events.

$6,000 - $10,000 / engagement

Strategic Policy Advisory
$6,000.00

Retained monthly counsel. CMS policy navigation, federal surveillance legislation, Capitol Hill engagement, public affairs strategy for CDI. For companies with active federal policy exposure.

$6,000 - $10,000 / month

Sales / Field Force Training
$6,000.00

Half-day (3-4 hours). Patient perspective, CDI disease burden, community impact, and advocate engagement strategies. Customized to product and audience.

$6,000 - $9,000 / session

Expert Commentary and Media Prep
$400.00

Press preparation, patient-facing messaging review, media strategy support.

$400 - $600 / hour